Continuous subcutaneous insulin infusion (CSII) with a portable insulin pump has been
used for several years in the treatment of adult patients with diabetes mellitus (DM). This …

The study assessed 3.5-year treatment with continuous subcutaneous insulin infusion (CSII)
in well-controlled children with duration of type 1 diabetes mellitus longer than 1 year …

Conclusion Pump therapy appears to be an acceptable form of management for insulin-
dependent diabetes in the younger age group. Size of the pump coupled with the need for …

Continuous subcutaneous insulin infusion (CSII) by external pumps is shown in several
clinical trials to be a safe and effective treatment modality for patients with T1D. The present …

Aim: To compare the long-term outcomes of continuous subcutaneous insulin infusion (CSII)
pump therapy with the clinical and metabolic parameters recorded during multiple daily …

Seven diabetic children (age: 8-12 y.) participated in a study comparing CSII and
conventional treatment (CT) under the same monitoring and supervision for a year. The aim …

Continuous subcutaneous insulin infusion (CSII) has been used in the paediatric age group
for more than 20 years. The technique is not yet widely used in most countries but there has …

Aims To determine the safety and effectiveness of continuous subcutaneous insulin infusion
(CSII) in attaining long‐term glycaemic control in paediatric patients with Type 1 diabetes …

Insulin‐dependent diabetes mellitus usually presents in childhood. Since it is generally
accepted that persisting metabolic derangements contribute to the development of microand …

Aim: To evaluate blood glucose and HbAu levels, insulin dosage, hypoglycemia rate and
body mass index (BMI) at baseline, and at 3 and 6 months after initiation of continuous …